https://www.reuters.com/article/us-health-coronavirus-gile...

The Chinese trial showed the antiviral remdesivir did not improve patients’ condition or reduce the pathogen’s presence in the bloodstream, the report said, citing draft documents published accidentally by the World Health Organization (WHO).

Gilead said in a statement the post included inappropriate characterizations of the study and that the study was terminated early due to low enrollment and, as a result, it was underpowered to enable statistically meaningful conclusions.

“The study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the company said.

The WHO said a draft document provided by the authors of the study was inadvertently posted on the website. It was taken down as soon as the mistake was noticed, the agency said adding the manuscript is undergoing peer review and a final version is awaited.

Если коротко, то ремдезивир скорей всего бесполезен против короны. Окончательные результаты исследования еще не опубликованы, но это следует из случайно утекшего черновика.